Leadiant responds to Dutch watchdog’s fine for excessive prices
MLex Summary: Pharmaceutical company Leadiant has said that it disagrees with the decision by the Autoriteit Consument & Markt to impose a fine of 19 million euros regarding the drug CDCA-Leadiant. The company...To view the full article, register now.
Already a subscriber? Click here to view full article